GRI Bio, Inc.
GRI
$1.60
$0.04412.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -26.23% | 46.67% | 14.80% | -20.00% | -72.69% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 28.36% | 61.00% | -3.55% | -2.70% | -61.96% |
| Operating Income | -28.36% | -61.00% | 3.55% | 2.70% | 61.96% |
| Income Before Tax | -28.53% | -61.42% | -189.77% | 0.66% | 66.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.53% | -61.42% | -189.77% | 0.66% | 66.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.53% | -61.42% | -189.77% | 0.66% | 66.65% |
| EBIT | -28.36% | -61.00% | 3.55% | 2.70% | 61.96% |
| EBITDA | -28.37% | -61.03% | 3.56% | 2.70% | 61.98% |
| EPS Basic | 97.88% | 94.27% | 93.40% | 90.41% | 48.06% |
| Normalized Basic EPS | 97.88% | 94.27% | -- | -- | -- |
| EPS Diluted | 97.88% | 94.27% | 86.80% | 90.41% | 48.06% |
| Normalized Diluted EPS | 97.88% | 94.27% | -- | -- | -- |
| Average Basic Shares Outstanding | 5,957.97% | 2,709.63% | -- | -- | -- |
| Average Diluted Shares Outstanding | 5,957.97% | 2,709.63% | 2,612.71% | 927.07% | 101.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |